Source link : https://newshealth.biz/health-news/genomic-test-may-spare-more-patients-with-node-positive-breast-cancer-from-chemo/
The phase III OPTIMA trial, presented at this year’s American Society of Clinical Oncology (ASCO) annual meeting, showed that some patients with high-risk, early-stage, estrogen receptor (ER)-positive, HER2-negative breast cancer may be able to avoid chemotherapy based on genomic testing, without compromising outcomes. MedPage Today brought together three expert leaders in the field: Moderator Hope […]
The post Genomic Test May Spare More Patients With Node-Positive Breast Cancer From Chemo first appeared on News Health.
—-
Author : News Health
Publish date : 2026-06-09 16:18:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8